Speaker Profile

Ph.D., Senior Manager Applications, ImmonoOncology and Vaccines, MBL International

Dr. Pirouz M Daftarian is a cellular and molecular immunologist with 20-year experience in Immuno-Oncology and vaccinology. Pirouz is currently a Senior Manager of Applications, IO and Vaccines at MBLI and JSR Micro. He has completed his PhD in the University of Ottawa and completed a postdoctoral fellowship on cancer biology and vaccines in the City of Hope National Medical Center. Prior to MBLI, Pirouz has led and shepherded R&D operations of in biotech companies (NGM Biopharmaceutical and Immunovaccine), has served as a faculty of the Miller School of Medicine, acted as a reviewer for DOD and NIH/NCI, and is the principal inventor of several vaccine and IO related regular patents. He has authored more than 60 research papers.

Immunotherapy Showcase: MBL International
MBL is a leading life science company focused on providing high-quality products & solutions for life science research and clinical diagnostics.

What Makes A Person Responder To ICI?
We present a T cell exhaustion model that may be reversed by immune checkpoint blockades (ICB) dividing hosts into responders and non-responders. This system creates a potential candidate model to study the biomarkers of responsiveness to IBCs.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.